Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of products to improve human and animal health. The Company's operations are principally managed on a products basis and consist of two business segments. The Pharmaceutical segment includes human health pharmaceutical products marketed either directly or through joint ventures. These products consist of therapeutic and preventive agents, sold by prescription, for the treatment of human disorders. The Vaccines and Infectious Diseases segment includes human health vaccine products marketed either directly or through a joint venture. These products consist of preventative pediatric, adolescent and adult vaccines, primarily administered at physician offices. Infectious disease products consist of therapeutic agents for the treatment of infection sold primarily to drug wholesalers and retailers, hospitals and government agencies.

Filers who had this stock in their top 10: 98
13F Filers holding this stock: 1635
Aggregate shares on 09/30/2015: 2,064,997,893
Aggregate shares on 06/30/2015: 2,079,442,628
Percent change: -0.69%
Funds creating new positions: 61
Funds Adding to an existing position: 729
Funds closing out their position: 99
Funds reducing their position: 621
Heat Map Ranking for 09/30/2015 121
Heat Map Ranking for 06/30/2015 372
View recent insider trading info

13F Filers holding this stock

Quarter 1: Refresh

Changes in Holdings:

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Schedule 13D and 13G filings submitted since 09/30/2015

Subscription required

Elevate your investments